|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNA2-1-E |
Cyclin A2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
355 |
0.27 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
355 |
0.27 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1904 |
0.24 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.35 |
Binding ≤ 10μM
|
PLK2-1-E |
Serine/threonine-protein Kinase PLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
238 |
0.28 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
450 |
0.27 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
587 |
0.26 |
Binding ≤ 10μM
|
Z104294-1-O |
Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other |
Other |
219 |
0.28 |
Binding ≤ 10μM
|
Z104296-1-O |
Cyclin-dependent Kinase 1/cyclin B1 (cluster #1 Of 2), Other |
Other |
160 |
0.29 |
Binding ≤ 10μM
|
Z104299-1-O |
Cyclin-dependent Kinase 2/cyclin E1 (cluster #1 Of 1), Other |
Other |
347 |
0.27 |
Binding ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
44 |
0.31 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
25 |
0.32 |
Functional ≤ 10μM
|
Z80942-1-O |
HEL (Embryonic Lung Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
73 |
0.30 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.49 |
7.93 |
-49.42 |
4 |
10 |
1 |
116 |
449.539 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CDC7-1-E |
Cell Division Cycle 7-related Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.70 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
250 |
0.58 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
240 |
0.58 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
460 |
0.55 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
34 |
0.65 |
Binding ≤ 10μM
|
CHK2-1-E |
Serine/threonine-protein Kinase Chk2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.52 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
220 |
0.58 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3010 |
0.48 |
Binding ≤ 10μM
|
KS6A5-2-E |
Ribosomal Protein S6 Kinase Alpha 5 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2340 |
0.49 |
Binding ≤ 10μM
|
MAPK2-1-E |
MAP Kinase-activated Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.55 |
Binding ≤ 10μM
|
MAPK5-1-E |
MAP Kinase-activated Protein Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.55 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2670 |
0.49 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
171 |
0.59 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
980 |
0.53 |
Binding ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
5000 |
0.46 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
5870 |
0.46 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1330 |
0.51 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
4590 |
0.47 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
860 |
0.53 |
Functional ≤ 10μM
|
Z80525-1-O |
SW48 (cluster #1 Of 2), Other |
Other |
1200 |
0.52 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
2670 |
0.49 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
1490 |
0.51 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
970 |
0.53 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
1100 |
0.52 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
3200 |
0.48 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
1830 |
0.50 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
3810 |
0.47 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
1600 |
0.51 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.64 |
2.58 |
-15.17 |
2 |
4 |
0 |
58 |
213.24 |
1 |
↓
|
Lo
Low (pH 4.5-6)
|
0.64 |
2.88 |
-44.62 |
3 |
4 |
1 |
59 |
214.248 |
1 |
↓
|
|
|
Analogs
-
22058336
-
-
6532
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 62 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100515-1-O |
HPAC (Pancreatic Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
73 |
0.56 |
Functional ≤ 10μM |
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.64 |
Functional ≤ 10μM |
Z100757-1-O |
SW1573 (Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
8300 |
0.40 |
Functional ≤ 10μM
|
Z103393-1-O |
SK-N-AS (cluster #1 Of 1), Other |
Other |
1100 |
0.46 |
Functional ≤ 10μM |
Z103407-1-O |
SW1990 (cluster #1 Of 2), Other |
Other |
1200 |
0.46 |
Functional ≤ 10μM
|
Z80048-1-O |
BXPC-3 (Pancreatic Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
160 |
0.53 |
Functional ≤ 10μM
|
Z80076-1-O |
CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other |
Other |
30 |
0.59 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
36 |
0.58 |
Functional ≤ 10μM
|
Z80132-1-O |
EL4 (Thymoma Cells) (cluster #1 Of 2), Other |
Other |
7 |
0.63 |
Functional ≤ 10μM |
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
330 |
0.50 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
43 |
0.57 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
746 |
0.48 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7 |
0.63 |
Functional ≤ 10μM |
Z80224-9-O |
MCF7 (Breast Carcinoma Cells) (cluster #9 Of 14), Other |
Other |
80 |
0.55 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
9 |
0.63 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
40 |
0.58 |
Functional ≤ 10μM
|
Z80457-1-O |
SCC-25 (cluster #1 Of 1), Other |
Other |
47 |
0.57 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
10 |
0.62 |
Functional ≤ 10μM
|
Z80478-1-O |
SK-LU-1 (cluster #1 Of 1), Other |
Other |
55 |
0.56 |
Functional ≤ 10μM
|
Z80482-2-O |
SK-MEL-2 (Melanoma Cells) (cluster #2 Of 4), Other |
Other |
7110 |
0.40 |
Functional ≤ 10μM |
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
1700 |
0.45 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
91 |
0.55 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
130 |
0.54 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.55 |
Functional ≤ 10μM
|
Z80702-1-O |
BG-1 Cell Line (cluster #1 Of 1), Other |
Other |
680 |
0.48 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
9 |
0.63 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.62 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
4 |
0.65 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
5 |
0.65 |
Functional ≤ 10μM
|
Z80742-1-O |
C6 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
504 |
0.49 |
Functional ≤ 10μM |
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
130 |
0.54 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
10 |
0.62 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
8 |
0.63 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
35 |
0.58 |
Functional ≤ 10μM
|
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
45 |
0.57 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
512 |
0.49 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
8 |
0.63 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
245 |
0.51 |
Functional ≤ 10μM |
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.62 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
22 |
0.60 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
9880 |
0.39 |
ADME/T ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.60 |
-4.98 |
-22.45 |
4 |
7 |
0 |
111 |
263.2 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 16 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z101697-1-O |
Camelpox Virus (cluster #1 Of 1), Other |
Other |
8800 |
0.39 |
Functional ≤ 10μM
|
Z101794-1-O |
Felid Herpesvirus 1 (cluster #1 Of 1), Other |
Other |
1300 |
0.46 |
Functional ≤ 10μM |
Z101848-1-O |
Human Herpesvirus 8 (cluster #1 Of 1), Other |
Other |
64 |
0.56 |
Functional ≤ 10μM
|
Z102080-1-O |
Simplexvirus (cluster #1 Of 1), Other |
Other |
3300 |
0.43 |
Functional ≤ 10μM
|
Z102131-1-O |
Vaccinia Virus Copenhagen (cluster #1 Of 1), Other |
Other |
9800 |
0.39 |
Functional ≤ 10μM
|
Z50515-2-O |
Human Herpesvirus 2 (cluster #2 Of 2), Other |
Other |
9500 |
0.39 |
Functional ≤ 10μM
|
Z50517-1-O |
Human Herpesvirus 5 Strain AD169 (cluster #1 Of 2), Other |
Other |
95 |
0.55 |
Functional ≤ 10μM
|
Z50518-3-O |
Human Herpesvirus 4 (cluster #3 Of 5), Other |
Other |
480 |
0.49 |
Functional ≤ 10μM
|
Z50527-3-O |
Human Herpesvirus 3 (cluster #3 Of 3), Other |
Other |
70 |
0.56 |
Functional ≤ 10μM |
Z50530-1-O |
Human Herpesvirus 5 (cluster #1 Of 5), Other |
Other |
940 |
0.47 |
Functional ≤ 10μM |
Z50599-1-O |
Cowpox Virus (cluster #1 Of 1), Other |
Other |
9000 |
0.39 |
Functional ≤ 10μM
|
Z50600-1-O |
Vaccinia Virus (cluster #1 Of 2), Other |
Other |
9400 |
0.39 |
Functional ≤ 10μM
|
Z50602-2-O |
Human Herpesvirus 1 (cluster #2 Of 5), Other |
Other |
570 |
0.49 |
Functional ≤ 10μM
|
Z50604-1-O |
Murid Herpesvirus 1 (cluster #1 Of 1), Other |
Other |
40 |
0.58 |
Functional ≤ 10μM
|
Z50624-1-O |
Human Adenovirus Type 2 (cluster #1 Of 1), Other |
Other |
3100 |
0.43 |
Functional ≤ 10μM
|
Z80291-2-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #2 Of 3), Other |
Other |
10000 |
0.39 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
500 |
0.49 |
Functional ≤ 10μM
|
Z80709-1-O |
Osteoclast-like (Bone Marrow Cells) (cluster #1 Of 1), Other |
Other |
10000 |
0.39 |
Functional ≤ 10μM
|
Z80942-1-O |
HEL (Embryonic Lung Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.48 |
Functional ≤ 10μM
|
Z80954-1-O |
HFF (Foreskin Fibroblasts) (cluster #1 Of 1), Other |
Other |
1900 |
0.44 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-2.70 |
-5.05 |
-52.83 |
4 |
9 |
-1 |
151 |
278.181 |
6 |
↓
|
|
|
Analogs
-
3918087
-
-
3938704
-
-
3995925
-
-
3995927
-
-
3995929
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1900 |
0.21 |
Binding ≤ 10μM
|
Z50460-3-O |
Leishmania Major (cluster #3 Of 4), Other |
Other |
380 |
0.24 |
Functional ≤ 10μM
|
Z80014-1-O |
A204 (Rhabdomyosarcoma Cells) (cluster #1 Of 1), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM |
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
63 |
0.27 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9 |
0.30 |
Functional ≤ 10μM |
Z80060-1-O |
CAPAN-1 (Pancreatic Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80134-1-O |
EVSA-T (cluster #1 Of 1), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
5 |
0.31 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
400 |
0.24 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
15 |
0.29 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
7 |
0.30 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
60 |
0.27 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
36 |
0.27 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
1 |
0.33 |
Functional ≤ 10μM |
Z80335-2-O |
NHDF (cluster #2 Of 2), Other |
Other |
404 |
0.24 |
Functional ≤ 10μM |
Z80342-1-O |
NSCLC (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.31 |
Functional ≤ 10μM |
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3 |
0.31 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
440 |
0.23 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.23 |
Functional ≤ 10μM |
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
1600 |
0.21 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z80571-1-O |
UCLA P-3 (cluster #1 Of 1), Other |
Other |
730 |
0.23 |
Functional ≤ 10μM |
Z80585-1-O |
WALKER (cluster #1 Of 1), Other |
Other |
47 |
0.27 |
Functional ≤ 10μM |
Z80606-1-O |
YOSHIDA (Sarcoma Cells) (cluster #1 Of 1), Other |
Other |
7 |
0.30 |
Functional ≤ 10μM |
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.26 |
Functional ≤ 10μM
|
Z80957-1-O |
HMEC (Microvascular Endothelial Cells) (cluster #1 Of 2), Other |
Other |
98 |
0.26 |
Functional ≤ 10μM |
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
7000 |
0.19 |
Functional ≤ 10μM |
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
700 |
0.23 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
380 |
0.24 |
Functional ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
83 |
0.26 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
640 |
0.23 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
16 |
0.29 |
Functional ≤ 10μM |
Z81159-1-O |
Lewis Cell Line (cluster #1 Of 1), Other |
Other |
61 |
0.27 |
Functional ≤ 10μM |
Z81227-1-O |
M-19 Cell Line (cluster #1 Of 1), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
977 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
2960 |
0.20 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
250 |
0.24 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
8600 |
0.19 |
Functional ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
880 |
0.22 |
ADME/T ≤ 10μM |
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
2500 |
0.21 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.90 |
1.34 |
-54.26 |
7 |
11 |
1 |
187 |
528.534 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
371 |
0.26 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
18 |
0.31 |
Binding ≤ 10μM
|
CSF1R-1-E |
Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
55 |
0.29 |
Binding ≤ 10μM
|
LCK-3-E |
Tyrosine-protein Kinase LCK (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
38 |
0.30 |
Binding ≤ 10μM
|
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
450 |
0.25 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
TIE2-1-E |
Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
580 |
0.25 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
Z80005-2-O |
3T3 (Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
25 |
0.30 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
25 |
0.30 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
8 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.25 |
11.79 |
-16.6 |
1 |
6 |
0 |
70 |
484.939 |
6 |
↓
|
|